RADX

Radiopharm Theranostics Limited

RADX

Radiopharm Theranostics Limited

dashboardOverview

paymentsDividend

newspaperNews

Radiopharm Theranostics Limited

RADX

$ -

You can review earnings summary, quarterly trends, full-year progress, and detailed income statement data.

descriptionIncome Statement Summary

Updated: 06/30/2025FY2025 FY

Revenue

4M USD

YoY +1114.3%

Operating Income

-38M USD

YoY -4.2%

Net Income

-38M USD

YoY +20.0%

EPS

-5.28USD

YoY +85.3%

Quarterly Performance

Quarterly revenue and net income trend

RevenueOperating IncomeNet Income

No quarterly data available

Full-Year Progress

FY2025

Full-year forecast not available

Income Statement Details

Unit: USD

Item

2022

2023

2024

2025

Revenue

Cost of revenue

Gross profit

3.63M

3.59M

39,276

Research & development

Selling & marketing

Selling, general and administrative

Other operating expenses

Operating income

27.52M

16.53M

41.81M

-38.17M

Interest expense

Income before tax

Income tax expense

Net income

65,300

-38.24M

103,292

-38.34M

Unlock Long-Term Income Statement Data

Your current plan allows viewing financial data for the latest 1 year (annual only). Upgrade to the Standard Plan to view up to 3 years (including quarterly data), or the Premium Plan to access all historical data.

Standard Plan Premium Plan